Dynavax Technologies
DVAX
#5495
Rank
C$1.76 B
Marketcap
C$15.04
Share price
-0.64%
Change (1 day)
-16.37%
Change (1 year)

P/S ratio for Dynavax Technologies (DVAX)

P/S ratio as of December 2025 (TTM): 3.89

According to Dynavax Technologies 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.41. At the end of 2025 the company had a P/S ratio of 3.47.

P/S ratio history for Dynavax Technologies from 2004 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20253.47-43.7%
20246.16-20.77%
20237.78314.15%
20221.88-51.09%
20213.84-63.54%
202010.5-22.67%
201913.6-80.59%
201870.2-97.98%
2017> 100025045.31%
201613.8-95%
2015276418.98%
201453.216.11%
201345.8-14.64%
201253.6175.33%
201119.526.1%
201015.4708.02%
20091.91111.82%
20080.9025-93.74%
200714.4-80.83%
200675.21006.01%
20056.80-46.81%
200412.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Agenus
AGEN
1.27-67.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
2.66-31.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3.89-0.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5.18 33.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.81 23.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
2.30-40.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
2.36-39.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1.94-50.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
4.98 27.84%๐Ÿ‡บ๐Ÿ‡ธ USA